文献速递慢性肾脏病

CKD患者NSAIDs使用模式及其与其他镇痛药使用的关系

Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-08-15

本研究基于慢性肾功能不全队列(CRIC)3872例CKD患者、15917次访视配对,发现24%报告使用NSAIDs;基线eGFR每高10 ml/min per 1.73 m2与后续启动NSAIDs的 odds 升高相关(OR 1.44),而肾内科就诊与启动或持续使用NSAIDs的 odds 降低相关;启动或停用NSAIDs均与增加其他镇痛药及阿片类镇痛药数量相关。

要点

  • CKD患者中NSAIDs使用常见,但肾功能较差或就诊肾内科者使用较少。
  • 肾内科就诊与降低NSAIDs启动或持续使用的 odds 相关。
  • 启动或停用NSAIDs常伴随其他镇痛药或阿片类药物的补充或替代。

核心结论

  • CKD患者中NSAIDs使用常见,但肾功能较差或肾内科就诊者使用较少;启动或停用NSAIDs常伴随其他镇痛药(包括阿片类)的补充或替代,可能引入药物相关问题。

研究设计与样本

  • 慢性肾功能不全队列研究(CRIC)为观察性队列,2003-2008年纳入3939例21-74岁CKD成人,采用基于年龄的eGFR纳入标准。
  • 收集人口学、肾功能、临床因素及前30天NSAIDs或其他镇痛药使用报告。

主要发现

  • 24%的参与者在基线或至少一次随访访视中报告使用NSAIDs。
  • 前次访视eGFR每高10 ml/min per 1.73 m2,与后续访视启动NSAIDs的 odds 升高相关(OR 1.44;95% CI 1.34-1.56)。
  • 前次访视就诊肾内科与后续访视启动NSAIDs的 odds 降低相关(OR 0.70;95% CI 0.56-0.87),与持续使用NSAIDs的 odds 降低相关(OR 0.61;95% CI 0.46-0.81)。
  • 启动NSAIDs与增加其他镇痛药数量的 odds 升高相关(OR 1.52;95% CI 1.25-1.85),与增加阿片类镇痛药数量的 odds 升高相关(OR 1.92;95% CI 1.48-2.48)。
  • 停用NSAIDs与增加其他镇痛药数量的 odds 升高相关(OR 1.78;95% CI 1.39-2.28),与增加阿片类镇痛药数量的 odds 升高相关(OR 1.46;95% CI 1.04-2.03)。

临床怎么用

  • 在CKD患者中应关注NSAIDs使用,尤其是eGFR较高者,并强化肾内科就诊以降低NSAIDs启动或持续使用。
  • 当启动或停用NSAIDs时,需警惕其他镇痛药(包括阿片类)的补充或替代,评估药物相关问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Avoiding nonsteroidal anti-inflammatory drugs is important for safe CKD care. This study examined nonsteroidal anti-inflammatory drug use patterns and their association with other analgesic use in CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Chronic Renal Insufficiency Cohort Study is an observational cohort study that enrolled 3939 adults ages 21-74 years old with CKD between 2003 and 2008 using age-based eGFR inclusion criteria. Annual visits between June of 2003 and December of 2011 were organized into 15,917 visit-pairs (with an antecedent and subsequent visit) for 3872 participants with medication information. Demographics, kidney function, and clinical factors were ascertained along with report of nonsteroidal anti-inflammatory drug or other analgesic use in the prior 30 days. RESULTS: In our study, 24% of participants reported nonsteroidal anti-inflammatory drug use at baseline or at least one follow-up study visit. Having a 10 ml/min per 1.73 m2 higher eGFR level at an antecedent visit was associated with higher odds of starting nonsteroidal anti-inflammatory drugs at a subsequent visit (odds ratio, 1.44; 95% confidence interval, 1.34 to 1.56). Seeing a nephrologist at the antecedent visit was associated with lower odds of starting or staying on nonsteroidal anti-inflammatory drugs at a subsequent visit (odds ratio, 0.70; 95% confidence interval, 0.56 to 0.87 and odds ratio, 0.61; 95% confidence interval, 0.46 to 0.81, respectively). Starting and stopping nonsteroidal anti-inflammatory drugs were both associated with higher odds of increasing the number of other analgesics (odds ratio, 1.52; 95% confidence interval, 1.25 to 1.85 and odds ratio, 1.78; 95% confidence interval, 1.39 to 2.28, respectively) and higher odds of increasing the number of opioid analgesics specifically (odds ratio, 1.92; 95% confidence interval, 1.48 to 2.48 and odds ratio, 1.46; 95% confidence interval, 1.04 to 2.03, respectively). CONCLUSIONS: Nonsteroidal anti-inflammatory drug use is common among patients with CKD but less so among those with worse kidney function or those who see a nephrologist. Initiation or discontinuation of nonsteroidal anti-inflammatory drugs is often associated with supplementation with or replacement by, respectively, other analgesics, including opioids, which introduces possible drug-related problems when taking these alternative analgesics.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Zhan M, St Peter WL, Doerfler RM, et al. Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD. Clin J Am Soc Nephrol. 2017. PMID: 28811297. doi:10.2215/CJN.12311216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。